Quantcast

Latest Clinical trial Stories

2014-06-16 12:29:16

Aspire IRB and Midlands IRB become part of the WCG family, further expanding its geographic and program reach PRINCETON, N.J., June 16, 2014 /PRNewswire/ -- The WIRB-Copernicus Group ("WCG"), the world's largest provider of regulatory and ethical review services for clinical research, announced today that two independent review boards (IRBs) - Aspire IRB and Midlands IRB - have joined the Group. Located near San Diego, CA and Kansas City, MO, respectively, these companies expand...

2014-06-16 12:28:49

Underscoring its Commitment to Patient Advocacy and Care, My Clinical Study Buddy(SM) Mobile Apps to Help Boost Patient Engagement SAN DIEGO and BOSTON, June 16, 2014 /PRNewswire/ -- DIA 2014 50(th) Annual Meeting -- BBK Worldwide, a leading clinical trial marketing firm, today unveiled two new mobile apps for patient and site engagement, My Clinical Study Buddy(SM) and My Clinical Study Buddy(SM) Protocol Pointers Edition. Available for Apple(®) and Android((TM)) mobile phones and tablets,...

2014-06-16 12:28:45

New R&D Model Protects Performance in a Threatened Enrollment Landscape SAN DIEGO and BOSTON, June 16, 2014 /PRNewswire/ -- DIA 2014 50(th) Annual Meeting -- BBK Worldwide, the leader in patient recruitment, today unveiled a new specialty in clinical trial marketing: adaptive recruitment. Designed specifically to protect global enrollment integrity, within a changing or threatened landscape, adaptive recruitment helps sites and sponsors maximize tight budgets and timeframes by...

2014-06-16 12:25:48

Mobile app and electronic clinical outcome assessment technology provide easy to use solutions for clinical trials SAN DIEGO, June 16, 2014 /PRNewswire/ -- Bracket, a leading clinical trial specialty service provider, is demonstrating their most recent eClinical innovations this week at the 50th Annual Meeting of the Drug Industry Association. A mobile app, part of Bracket's Randomization and Trial Supply Management System (RTSM ) and Clinical Interactive Response Technologies...

2014-06-16 08:29:54

? eClinical Leader adds Risk-Based Monitoring Technology to Platform ? NEWTOWN, Pa., June 16, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials. This move adds Compass, a cloud-based site scoring tool to the robust...

2014-06-16 08:29:45

PHILADELPHIA, June 16, 2014 /PRNewswire/ -- TransCelerate BioPharma Inc. ("TransCelerate") is launching two new global initiatives enabled by broad participation and collaboration across the global research and development (R&D) community: develop a position on the best and most efficient methods for redacting privacy information found in clinical study reports and an approach for the anonymization of patient level data shared with the broader healthcare community; and develop a...

2014-06-16 08:29:32

The Lung-MAP trial uses a multi-drug, targeted screening approach to match patients with promising new cancer treatments based on their unique tumor profiles BETHESDA, Md., June 16, 2014 /PRNewswire/ -- A unique public-private collaboration among the National Cancer Institute (NCI), part of the National Institutes of Health, SWOG Cancer Research, Friends of Cancer Research (Friends), the Foundation for the National Institutes of Health (FNIH), five pharmaceutical companies (Amgen,...

2014-06-16 08:28:24

Sub-study will investigate effects of MST-188 on tissue oxygenation in sickle cell disease patients experiencing a vaso-occlusive crisis SAN DIEGO, June 16, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that, in line with prior guidance, it has initiated patient enrollment in a sub-study within EPIC, its pivotal phase 3 study of MST-188 in sickle cell disease, to investigate and quantify the effect of MST-188 on tissue oxygenation, which will be...

2014-06-16 04:21:36

LUGANO, Switzerland, June 16, 2014 /PRNewswire/ -- ESMO welcomes the adoption of the Clinical Trials Regulation by the EU The European Society for Medical Oncology (ESMO) has welcomed the adoption of the Clinical Trials Regulation [http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2014.158.01.0001.01.ENG ] by the EU, entering into force today. The new framework acknowledges the importance of using data stored for a clinical trial beyond the end of...

2014-06-15 08:20:51

LONDON, June 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/hormone_refractory_breast_cancer_global_clinical_trials_review_h1_2014.htmlHormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014 SummaryGlobalData's clinical trial report, "Hormone Refractory Breast Cancer Global Clinical Trials...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related